ArticleInvestigational new drugs2021

Trilostane, a 3β-hydroxysteroid dehydrogenase inhibitor, suppresses growth of hepatocellular carcinoma and enhances anti-cancer effects of sorafenib.

Jiunn-Chang Lin et al.PubMed ↗Publisher ↗

No numbers read from the abstract.